Brief: HCW Biologics Reports Fourth Quarter Results
28/03/2022 15:11
March 28 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS INC - ESTIMATES THAT IT HAS SUFFICIENT CASH
TO
FUND OPERATION EXPENSES TO END OF 2023
Source text for Eikon: ID:nGNX3SzvW2
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM